`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`Trademark Trial and Appeal Board
`P.O. Box 1451
`Alexandria, VA 22313-1451
`General Contact Number: 571-272-8500
`General Email: TTABInfo@uspto.gov
`
`January 16, 2019
`
`Opposition No. 91240294
`
`Quest Diagnostics Investments LLC
`
`v.
`
`
`
`Millicent Canady, Paralegal Specialist:
`
`PathoQuest
`
`Applicant’s consented motions filed December 3, 2018 and December 21, 2018, to
`
`extend time to file its answer to the notice of opposition is granted.1 Trademark Rule
`
`2.127(a). An answer must be filed through ESTTA, the Board’s Electronic System for
`
`Trademark Trials and Appeals. See Trademark Rule 2.106(b)(1)/2.114(b)(1).
`
`Accordingly, answer, conference, disclosure, discovery and trial dates, are reset as
`
`follows:
`
`Time to Answer
`Deadline for Discovery Conference
`Discovery Opens
`Initial Disclosures Due
`Expert Disclosures Due
`
`1/31/2019
`3/2/2019
`3/2/2019
`4/1/2019
`7/30/2019
`
`
`1 When parties stipulate to the rescheduling of a deadline for pretrial disclosures and
`subsequent testimony periods or to the rescheduling of the closing date for discovery and the
`rescheduling of subsequent deadlines for pretrial disclosures and testimony periods, a
`stipulation presented in the form used in a trial order, signed by the parties, or a motion in
`said form signed by one party and including a statement that every other party has agreed
`thereto, shall be submitted to the Board through ESTTA, with the relevant dates set forth
`and an express statement that all parties agree to the new dates. Trademark Rule 2.121(d).
`
`
`
`
`
`Opposition No. 91240294
`
`
`Discovery Closes
`Plaintiff's Pretrial Disclosures Due
`Plaintiff's 30-day Trial Period Ends
`Defendant's Pretrial Disclosures Due
`Defendant's 30-day Trial Period Ends
`Plaintiff's Rebuttal Disclosures Due
`Plaintiff's 15-day Rebuttal Period Ends
`Plaintiff's Opening Brief Due
`Defendant's Brief Due
`Plaintiff's Reply Brief Due
`Request for Oral Hearing (optional) Due
`
`8/29/2019
`10/13/2019
`11/27/2019
`12/12/2019
`1/26/2020
`2/10/2020
`3/11/2020
`5/10/2020
`6/9/2020
`6/24/2020
`7/4/2020
`
`
`Generally, the Federal Rules of Evidence apply to Board trials. Trial testimony is
`
`taken and introduced out of the presence of the Board during the assigned testimony
`
`periods. The parties may stipulate to a wide variety of matters, and many
`
`requirements relevant to the trial phase of Board proceedings are set forth in
`
`Trademark Rules 2.121 through 2.125. These include pretrial disclosures, the
`
`manner and timing of taking testimony, matters in evidence, and the procedures for
`
`submitting and serving testimony and other evidence, including affidavits,
`
`declarations, deposition transcripts and stipulated evidence. Trial briefs shall be
`
`submitted in accordance with Trademark Rules 2.128(a) and (b). Oral argument at
`
`final hearing will be scheduled only upon the timely submission of a separate notice
`
`as allowed by Trademark Rule 2.129(a).
`
`
`
`2
`
`



